Search Within

Mark E Robson

  1. "2022"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (12)
  3. Editorial (2)
  4. Review (2)
  5. Miscellaneous (1)
Groups
  1. Breast Medicine Service (34)
  2. Department of Medicine (34)
  3. Population Sciences Research Program (34)
  4. Solid Tumor Oncology Division (34)
  5. Survivorship Research (34)
  6. GSK Faculty (18)

More Groups

People
  1. Kenneth Offit (11)
  2. Diana Mandelker (9)
  3. Zsofia Stadler (9)
  4. Michael Berger (8)
  5. Ahmet Zehir (7)
  6. Jorge Reis-Filho (7)

More People

Years
  1. 2022 (34)
Publications
  1. Journal of Clinical Oncology (8)
  2. Annals of Surgical Oncology (4)
  3. Cancer Epidemiology Biomarkers and Prevention (2)
  4. Clinical Cancer Research (2)
  5. ASCO Connection (1)
  6. Annals of Behavioral Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (6)
  3. Springer (6)
  4. Nature Publishing Group (3)
  5. American Medical Association (2)
  6. Oxford University Press (2)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Delays in care following a COVID diagnosis
    Meeting Abstract

    Mullangi, S.; Aviki, E. M.; Chen, Y.; Robson, M. E.; Hershman, D. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cost effectiveness of adjuvant olaparib for BRCA-mutated, early-stage breast cancer
    Meeting Abstract

    Zettler, C.; De Silva, D.; Blinder, V. S.; Robson, M. E.; Elkin, E. B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • BRCA reversion mutations mediated by microhomology-mediated end joining (MMEJ) as a mechanism of resistance to PARP inhibitors in ovarian and breast cancer
    Meeting Abstract

    Lukashchuk, N.; Armenia, J.; Tobalina, L.; Carr, T. H.; Milenkova, T.; Liu, Y. L.; Penson, R. T.; Robson, M. E.; Harrington, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A breast cancer (BC) risk model incorporating Tyrer-Cuzick version 8 (TCv8) and a polygenic risk score (PRS) for diverse ancestries
    Meeting Abstract

    Hughes, E.; Probst, B.; Pederson, H. J.; Simmons, T.; Morris, B.; Domchek, S. M.; Eng, C.; Gary, M.; Gordon, O.; Klemp, J. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations
    Meeting Abstract

    Aftimos, P. G.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E. P.; Gucalp, A.; Shah, P. D.; de Miguel, M. J.; Sharma, P.; Bauman, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save